SCHEMBL19675522

SCHEMBL19675522

CC(C)C(=O)C1Nc2ccccc2S1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.44
HSD17B10 Q99714 4/20 0.38
GLA P06280 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
PKM P14618 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HTT P42858 1/20 0.38
BRD4 O60885 1/20 0.37
CREBBP Q92793 1/20 0.37
RAB9A P51151 1/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 3/20 0.36
GAA P10253 2/20 0.36
NOX1 Q9Y5S8 2/20 0.36
ALOX15 P16050 2/20 0.36
CYBB P04839 1/20 0.36
APP P05067 1/20 0.36
SNCA P37840 1/20 0.36
NOX3 Q9HBY0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14959585 0.81 IDO1 (0.48) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL27918261 0.80 IDO1 (0.52) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL31297773 0.80 IDO1 (0.52) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL23673718 0.79 IDO1 (0.50) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL24029284 0.78 IDO1 (0.42) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL12187940 0.77 IDO1 (0.44) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL29092445 0.73 IDO1 (0.52) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL12571712 0.69 IDO1 (0.52) IDO1HSD17B10GLAMEN1KMT2A
SCHEMBL15933851 0.69 MAPT (0.46) MAPTMAPK1BCHE
SCHEMBL38664322 0.67 IDO1 (0.38) IDO1HSD17B10GLAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed